According to research, miRNAs are thought to have a regulatory role in pancreatic cancer resistance to gemcitabine and regulate related pathways such as KRAS, PI3K-AKT, NF-kB, P53, and Hedgehog [75]. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.